Disclosures: The views expressed here reflect those of the authors and not the supporting agencies. The authors have no conflicts of interest.
METelemedicine: A Pilot Study With Rural Alcohol Users on Community Supervision
Article first published online: 6 MAY 2014
© 2014 National Rural Health Association
The Journal of Rural Health
Volume 30, Issue 4, pages 422–432, Autumn 2014
How to Cite
Staton-Tindall, M., Havens, J. R., Webster, J. M. and Leukefeld, C. (2014), METelemedicine: A Pilot Study With Rural Alcohol Users on Community Supervision. The Journal of Rural Health, 30: 422–432. doi: 10.1111/jrh.12076
Funding: This project was supported by funding from the National Institute on Alcohol Abuse and Alcoholism (R21-AA017937, Staton-Tindall, PI).
Acknowledgments: We also recognize the support and collaboration of the Kentucky Department of Corrections.
- Issue published online: 2 OCT 2014
- Article first published online: 6 MAY 2014
- National Institute on Alcohol Abuse and Alcoholism. Grant Number: R21-AA017937
- motivational enhancement therapy;
- rural treatment;
This pilot study examined a telemedicine-based intervention using motivational enhancement therapy (METelemedicine) to reduce alcohol use among a sample of at-risk, rural alcohol users.
A total of 127 rural alcohol users were recruited from community supervision offices and engaged in brief intervention sessions using telemedicine. Analysis examined alcohol outcomes at 3 months postbaseline.
Findings indicated that although there were no overall differences between comparison groups on alcohol outcomes, 3+ sessions of METelemedicine significantly reduced the likelihood of any alcohol use by 72% (P < .05). In addition, 3+ sessions of the intervention predicted fewer days of drinking in the follow-up period, fewer drinks per week, and fewer days experiencing alcohol problems.
Findings demonstrate that telemedicine may be a promising approach to deliver interventions with alcohol users who may not utilize formal treatment services. This method has potential to decrease some of the barriers to access and use of evidence-based treatment for populations in need of services.